Merck & Co., Inc.MRKNYSE
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-9.3%
5Y CAGR-12.3%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
-9.3%/yr
vs -10.7%/yr prior
5Y CAGR
-12.3%/yr
Recent acceleration
Acceleration
+1.4pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.46 | -1.7% |
| 2024 | 14.72 | -98.1% |
| 2023 | 778.71 | +3924.6% |
| 2022 | 19.35 | +30.2% |
| 2021 | 14.86 | -46.8% |
| 2020 | 27.92 | +23.6% |
| 2019 | 22.60 | -25.6% |
| 2018 | 30.37 | -49.7% |
| 2017 | 60.43 | +53.5% |
| 2016 | 39.36 | - |